Donor steatosis represents a well-known risk factor for primary non-function, early allograft dysfunction, and biliary complications after liver transplantation (LT). Recently, machine perfusion (MP) technology has been implemented in the clinical practice, with the primary intent to assess the graft quality and to optimize the organ selection process. A limited number of articles has been published specifically investigated the role of MP in steatotic livers, with few of them looking at the role of hypothermic MP.
Hypothermic oxygenated perfusion for a steatotic liver graft / Lai, Quirino; Ruberto, Franco; Melandro, Fabio; Larghi Laureiro, Zoe; Rossi, Massimo; Mennini, Gianluca. - In: HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL. - ISSN 1499-3872. - (2019). [10.1016/j.hbpd.2019.05.012]
Hypothermic oxygenated perfusion for a steatotic liver graft
Lai, Quirino
;Ruberto, Franco;Melandro, Fabio;Larghi Laureiro, Zoe;Rossi, Massimo;Mennini, Gianluca
2019
Abstract
Donor steatosis represents a well-known risk factor for primary non-function, early allograft dysfunction, and biliary complications after liver transplantation (LT). Recently, machine perfusion (MP) technology has been implemented in the clinical practice, with the primary intent to assess the graft quality and to optimize the organ selection process. A limited number of articles has been published specifically investigated the role of MP in steatotic livers, with few of them looking at the role of hypothermic MP.| File | Dimensione | Formato | |
|---|---|---|---|
|
Lai_Hypothermic-oxygenated-perfusion_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1 MB
Formato
Adobe PDF
|
1 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
